PURPOSE: To determine the electroclinical significance and histopathological correlates of cortical gamma-aminobutyric acid(A)(GABA(A)) receptor abnormalities detected in and remote from human neocortical epileptic foci. METHODS: Cortical areas with decreased(11)C-flumazenil (FMZ) binding were objectively identified on positron emission tomography (PET) images and correlated to intracranial electroencephalography (EEG) findings, clinical seizure variables, histology findings, and surgical outcome in 20 patients (mean age, 9.9 years) with intractable partial epilepsy of neocortical origin and nonlocalizing magnetic resonance imaging (MRI). RESULTS: Focal decrease of cortical FMZ binding was detected in the lobe of seizure onset in 17 (85%) patients. Eleven patients (55%) had 17 remote cortical areas with decreased FMZ binding outside the lobe of seizure onset. Thirteen of those 16 (81%) of the 17 remote cortical regions that were covered by subdural EEG were around cortex showing rapid seizure spread on intracranial EEG. Remote FMZ PET abnormalities were associated with high seizure frequency and, when resected, showed gliosis in all six cases where material was available. Higher number of unresected cortical regions with decreased FMZ binding was associated with poorer surgical outcome. CONCLUSIONS: Focal decreases of cortical GABA(A) receptor binding on PET may include cortical regions remote from the primary focus, particularly in patients with high seizure frequency, and these regions are commonly involved in rapid seizure propagation. Although these regions may not always need to be resected to achieve seizure freedom, a careful evaluation of cortex with decreased GABA(A) receptor binding prior to resection using intracranial EEG may facilitate optimal surgical outcome in patients with intractable neocortical epilepsy.
PURPOSE: To determine the electroclinical significance and histopathological correlates of cortical gamma-aminobutyric acid(A)(GABA(A)) receptor abnormalities detected in and remote from human neocortical epileptic foci. METHODS: Cortical areas with decreased(11)C-flumazenil (FMZ) binding were objectively identified on positron emission tomography (PET) images and correlated to intracranial electroencephalography (EEG) findings, clinical seizure variables, histology findings, and surgical outcome in 20 patients (mean age, 9.9 years) with intractable partial epilepsy of neocortical origin and nonlocalizing magnetic resonance imaging (MRI). RESULTS: Focal decrease of cortical FMZ binding was detected in the lobe of seizure onset in 17 (85%) patients. Eleven patients (55%) had 17 remote cortical areas with decreased FMZ binding outside the lobe of seizure onset. Thirteen of those 16 (81%) of the 17 remote cortical regions that were covered by subdural EEG were around cortex showing rapid seizure spread on intracranial EEG. Remote FMZ PET abnormalities were associated with high seizure frequency and, when resected, showed gliosis in all six cases where material was available. Higher number of unresected cortical regions with decreased FMZ binding was associated with poorer surgical outcome. CONCLUSIONS: Focal decreases of cortical GABA(A) receptor binding on PET may include cortical regions remote from the primary focus, particularly in patients with high seizure frequency, and these regions are commonly involved in rapid seizure propagation. Although these regions may not always need to be resected to achieve seizure freedom, a careful evaluation of cortex with decreased GABA(A) receptor binding prior to resection using intracranial EEG may facilitate optimal surgical outcome in patients with intractable neocortical epilepsy.
Authors: Asla Pitkänen; Jari Nissinen; Jaak Nairismägi; Katarzyna Lukasiuk; Olli H J Gröhn; Riitta Miettinen; Risto Kauppinen Journal: Prog Brain Res Date: 2002 Impact factor: 2.453
Authors: Alexander Hammers; Matthias J Koepp; Mark P Richardson; René Hurlemann; David J Brooks; John S Duncan Journal: Brain Date: 2003-06 Impact factor: 13.501
Authors: Oleg Korzyukov; Eishi Asano; Valentina Gumenyuk; Csaba Juhász; Michael Wagner; Robert D Rothermel; Harry T Chugani Journal: Brain Topogr Date: 2009-08-22 Impact factor: 3.020
Authors: Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle Journal: Mol Imaging Biol Date: 2012-02 Impact factor: 3.488
Authors: Michael E Behen; Csaba Juhász; Cortney Wolfe-Christensen; William Guy; Stacey Halverson; Robert Rothermel; James Janisse; Harry T Chugani Journal: Epilepsy Behav Date: 2011-10 Impact factor: 2.937
Authors: Jason S Naftulin; Omar J Ahmed; Giovanni Piantoni; Jean-Baptiste Eichenlaub; Louis-Emmanuel Martinet; Mark A Kramer; Sydney S Cash Journal: Epilepsia Date: 2018-06-13 Impact factor: 5.864